4.7 Editorial Material

When one and one make three - HLA and EBV infection in MS

Journal

NEUROLOGY
Volume 70, Issue 13, Pages 1067-1068

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/01.wnl.0000307665.91437.cf

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Clinical Neurology

Prescription opioid use in multiple sclerosis

Ruth Ann Marrie, John D. Fisk, Randy Walld, James M. Bolton, Jitender Sareen, Scott B. Patten, Alexander Singer, Lisa M. Lix, Carol A. Hitchon, Renee El-Gabalawy, Alan Katz, James J. Marriott, Charles N. Bernstein

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Clinical Neurology

Low socioeconomic status was associated with a higher mortality risk in multiple sclerosis

Floriane Calocer, Huah Shin Ng, Feng Zhu, Yinshan Zhao, Olivier Dejardin, Emmanuelle Leray, Gilles Defer, Charity Evans, John D. Fisk, Ruth Ann Marrie, Helen Tremlett

Summary: The study found that lower socioeconomic status is associated with a higher mortality risk in persons with multiple sclerosis (PwMS).

MULTIPLE SCLEROSIS JOURNAL (2023)

Article Endocrinology & Metabolism

Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study

Wajd Alkabbani, Colleen J. Maxwell, Ruth Ann Marrie, Suzanne L. Tyas, Iliana C. Lega, John-Michael Gamble

Summary: This study reveals that both mid- and late-life hypoglycemia are associated with a doubled risk of dementia. Patients who experienced severe hypoglycemic events in mid- and late-life have a higher risk of developing dementia compared to those without hypoglycemia.

DIABETES CARE (2023)

Article Clinical Neurology

Family health conditions and parental occupational status modify the relationship between pediatric-onset multiple sclerosis and parental health-related quality of life

Julia O'Mahony, Brenda Banwell, Audrey Laporte, Adalsteinn Brown, Lady Bolongaita, Amit Bar-Or, E. Ann Yeh, Ruth Ann Marrie

Summary: Understanding the factors that influence the relationship between a child's MS diagnosis and parental HRQoL can help improve interventions for both parents and children with MS. The study found that the combination of a child's MS diagnosis with a family health condition or low SEP has a synergistic effect on parental HRQoL. Parents of children with MS who also have other family health conditions or a low SEP are at higher risk for low HRQoL.

MULTIPLE SCLEROSIS JOURNAL (2023)

Article Endocrinology & Metabolism

Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study

Wajd Alkabbani, Colleen J. J. Maxwell, Ruth Ann Marrie, Suzanne L. L. Tyas, Iliana C. C. Lega, John-Michael Gamble

Summary: This study reevaluates the association between insulin use and dementia risk in type 2 diabetes patients, considering confounding factors. The results showed no significant association between insulin use and all-cause dementia in patients previously treated with two noninsulin antihyperglycemic medications.

DIABETES CARE (2023)

Article Gastroenterology & Hepatology

Psychometric Performance of Fatigue Scales in Inflammatory Bowel Disease

Ruth Ann Marrie, John D. Fisk, Casandra Dolovich, Lisa M. Lix, Lesley A. Graff, Scott B. Patten, Charles N. Bernstein

Summary: This study compared the psychometric properties of multiple fatigue scales in individuals with inflammatory bowel disease (IBD). The Fatigue Impact Scale (FIS), Modified Fatigue Impact Scale-IBD (MFIS-IBD), and Daily Fatigue Impact Scale (DFIS) showed adequate validity and reliability for assessing fatigue in IBD.

INFLAMMATORY BOWEL DISEASES (2023)

Article Clinical Neurology

Clinical course of multiple sclerosis and patient experiences during breast cancer treatment

Alyssa N. Nylander, Jessica Singh, Shane Poole, Annika Anderson, Ruth Ann Marrie, Hope Rugo, Riley Bove

Summary: In this study, a case series of multiple sclerosis (MS) patients diagnosed with breast cancer was analyzed retrospectively to understand the clinical characteristics and treatment strategies. The study found that the relapse rate of MS during breast cancer treatment was low, and the neurologic function scores of the patients remained stable. This study provides valuable information for understanding the clinical management of patients with concurrent MS and breast cancer.

MULTIPLE SCLEROSIS JOURNAL (2023)

Article Medicine, General & Internal

Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study

Carol A. Hitchon, Christine Mesa, Charles N. Bernstein, Ruth Ann Marrie, Catherine Card, Sheila F. O'Brien, John Kim

Summary: This study compared antibody responses and disease activity/states in individuals with immune-mediated inflammatory diseases (IMIDs) who received SARS-CoV-2 vaccines. The results showed that heterologous vaccination improved seroconversion rates and did not lead to disease flare. Therefore, IMID patients benefit from receiving at least three doses of the vaccine.

BMJ OPEN (2023)

Article Medicine, General & Internal

Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada: a cross-sectional study

Shaza Almweisheer, Charles N. Bernstein, Lesley A. Graff, Scott B. Patten, James Bolton, John D. Fisk, Carol A. Hitchon, James J. Marriott, Ruth Ann Marrie

Summary: This study aimed to assess the mental health of individuals with immune-mediated inflammatory diseases (IMID) and compare the differences across different types of diseases. The study found that over half of the participants with multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA) reported flourishing mental health, with similar levels across the disease groups.

BMJ OPEN (2023)

Article Clinical Neurology

Severity and worsening of fatigue among individuals with multiple sclerosis

Amber Salter, Alexander Keenan, Hoa H. Le, Kavita Gandhi, Maria Ait-Tihyaty, Samantha Lancia, Gary R. Cutter, Robert J. Fox, Ruth Ann Marrie

Summary: Fatigue is commonly experienced by multiple sclerosis patients, with a majority reporting worsening of fatigue over time. Factors associated with fatigue worsening include lower income, higher disability, lower initial fatigue level, use of injectable disease-modifying therapies, and increased levels of depression.

MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2023)

Article Clinical Neurology

Incidence and prevalence of paediatric-onset multiple sclerosis in two Canadian provinces: a population-based study representing over half of Canada's population

Fardowsa L. A. Yusuf, Ayesha Asaf, Ruth Ann Marrie, Ping Li, Kyla McKay, Yinshan Zhao, Feng Zhu, Colleen Maxwell, Helen Tremlett

Summary: Canada has one of the highest rates of paediatric-onset multiple sclerosis (PoMS) globally, and the prevalence, but not incidence, has increased over time. Allocation of resources to support the growing youth population with MS should be a priority.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Review Clinical Neurology

Assessing heterogeneity of treatment effect in multiple sclerosis trials

Maria Pia Sormani, Jeremy Chataway, David M. Kent, Ruth Ann Marrie

Summary: Multiple sclerosis (MS) has varied outcomes, and evaluating heterogeneity of treatment effect (HTE) is important. Various statistical techniques can assess HTE, with multivariable predictive approaches offering more patient-centered results. This review examines methods used to estimate HTE in MS clinical trials.

MULTIPLE SCLEROSIS JOURNAL (2023)

Review Clinical Neurology

Improving the efficiency of clinical trials in multiple sclerosis

Ruth Ann Marrie, Maria Pia Sormani, Sean Apap Mangion, Francesca Bovis, Winson Y. Cheung, Gary R. Cutter, Peter Feys, Michael D. Hill, Marcus Werner Koch, Morgan McCreary, Ellen M. Mowry, Jay J. H. Park, Fredrik Piehl, Amber Salter, Jeremy Chataway

Summary: The current designs for clinical trials treating progressive multiple sclerosis (MS) have limitations and have not been successful. This paper discusses complex innovative trial designs and intermediate and composite outcomes to improve trial design efficiency in MS. Recommendations include increasing the use of complex innovative designs, developing biomarkers to enrich trial populations, prioritizing intermediate outcomes targeting therapeutic mechanisms, and investigating data linkage for long-term outcomes. Novel trial designs and further development of intermediate outcomes may improve clinical trial efficiency and address novel therapeutic questions in MS.

MULTIPLE SCLEROSIS JOURNAL (2023)

Article Clinical Neurology

Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosis

Dhruv Jain, Charles N. Bernstein, Lesley A. Graff, Scott B. Patten, James M. Bolton, John D. Fisk, Carol Hitchon, James J. Marriott, Ruth Ann Marrie

Summary: This study compared the prevalence of pain and the association between pain and pain interference, as well as social participation, in different subtypes of multiple sclerosis. The results showed that pain was common among all participants, with no differences between subtypes. However, individuals with progressive multiple sclerosis reported higher pain interference and lower social participation compared to those with relapsing-remitting multiple sclerosis.

MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2023)

Letter Endocrinology & Metabolism

Insulin, hypoglycaemia and dementia: A causal mediation analysis showcasing challenges and potential opportunities

Wajd Alkabbani, Colleen J. Maxwell, Ruth Ann Marrie, Suzanne L. Tyas, Iliana C. Lega, John-Michael Gamble

DIABETES OBESITY & METABOLISM (2023)

No Data Available